1. 614TiPUCGI 28 Panirinox: A randomized phase II study assessing Panitumumab + FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis. (23rd October 2018) Authors: Mazard, T; Ghiringhelli, F; Mollevi, C; Assenat, E; Gavoille, C; Smith, D; Pezzella, V; Meddeb, R; Pastor, B; Ychou, M; Thierry, A R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 972PBcl-2 proteins expression and response to navitoclax in platinum resistant/refractory recurrent ovarian cancer (PROC). (23rd October 2018) Authors: Brachet, P E; Joly Lobbedez, F; Fabbro, M; Leary, A; Medioni, J; Follana, P; Lesoin, A F; Frenel, J-S; Abadie Lacourtoisie, S; Floquet, A; Gladieff, L; You, B; Gavoille, C; Kalbacher, E; Briand, M; Just, P A; Blanc-Fournier, C; Giffard, F; Clarisse, B; Poulain, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗